7.4 Pediatric, Pregnant & Repeat-Exposure Considerations

Protecting the Most Vulnerable Patients

The final layer of patient protection addresses populations with heightened radiosensitivity and the single largest avoidable dose source — the repeat exposure.

Pediatric Dose Reduction

Children are more radiosensitive than adults because, per the Law of Bergonié and Tribondeau, actively dividing and immature cells are more vulnerable; children also have a longer latent period ahead of them to express stochastic effects such as cancer. Pediatric protection therefore aims aggressively at ALARA:

• Reduce technique: use lower mAs and, where contrast allows, higher kVp; smaller, thinner bodies need far less exposure than adult defaults.
• Immobilize: devices such as the Pigg-O-Stat, sandbags, sponges, and tape prevent motion — the leading cause of a pediatric repeat. Immobilization protects dose by preventing re-exposure.
• Collimate tightly to the small anatomy to cut integral dose and scatter.
• Remove the grid for thin parts (< 10–12 cm) since a grid would only add dose.
• Use AEC cautiously: small anatomy may not cover the chamber, so manual technique is often safer and more reliable.
• Apply Image Gently: child-size technique charts and the "child-size the kVp and mAs" philosophy.

Parent-assisted holding (with the parent, not staff, wearing protection) is preferred over repeats when immobilization fails.

The Pregnant Patient

Protection of the embryo/fetus begins with screening: every patient of childbearing potential is asked for her last menstrual period (LMP) and pregnancy status before abdominal or pelvic imaging, and posted signage reinforces the question. Two historical scheduling rules appear on the ARRT:

The 10-day rule was designed to avoid irradiating an unrecognized early pregnancy but proved impractical and is now largely replaced by the 28-day rule and by treating every woman of childbearing potential as potentially pregnant until confirmed otherwise. If an exam is medically necessary, it proceeds using ALARA — collimation, optimized technique, and documentation; elective exams of the gravid abdomen may be postponed. On fetal risk, know the NCRP benchmarks: diagnostic fetal doses below roughly 50–100 mGy (5–10 rad) are not associated with a measurable increase in malformation or pregnancy loss above background, and deterministic thresholds sit around 100–200 mGy. A single diagnostic study — an abdomen delivers only a few mGy to the fetus, and a chest or extremity essentially none — falls far below these levels. This context prevents both unnecessary alarm and unjustified refusal of needed imaging.

Gestational timing also matters. The embryo is most vulnerable to organogenesis effects during the second through eighth weeks, when major organ systems form; the pre-implantation period (roughly the first two weeks) follows an "all-or-nothing" pattern; and central-nervous-system sensitivity peaks around weeks 8–15. These windows explain why screening and elective postponement focus on early pregnancy, but they do not change the core message that diagnostic-level doses remain below the thresholds for measurable harm. When a pregnant patient must be imaged, the radiographer documents the clinical justification, collimates tightly, and — where it will not obscure anatomy or interfere with AEC — may still apply abdominal shielding, consistent with the newer guidance that de-emphasizes routine (but not clinically requested) fetal shielding.

Reducing Repeat Exposures

A repeat exposure directly doubles the dose to that anatomy (and doubles department workload), making repeat avoidance one of the highest-yield ALARA actions. Positioning errors are the leading cause of repeats, followed by exposure-factor errors, motion, artifacts, and patient-identification problems. Facilities run repeat/reject analysis programs, often targeting an overall repeat rate under about 5–8%, to find and fix recurring error patterns.

The most tested concept: in digital imaging, brightness and contrast are display parameters adjusted by windowing (window level and width) in post-processing — they are not reasons to repeat, because re-exposing to fix a display appearance adds dose for nothing. A repeat is justified only for a true diagnostic loss: incorrect positioning, motion blur, anatomy clipped or collimated out of the field, or a foreign-body/artifact that hides pathology. Practical repeat-prevention steps include verifying the correct part, projection, and marker before exposure; confirming AEC chamber selection; giving clear breathing and motion instructions; and immobilizing when needed. Getting the exposure right the first time is the purest expression of patient ALARA.

Repeat/reject analysis also carries a quality-improvement angle the ARRT may probe. A well-run program categorizes rejects by cause — positioning, exposure, motion, artifact, patient ID, equipment — so a facility can target the biggest driver with focused retraining rather than blanket technique changes. A rising repeat rate concentrated in one projection points to a workflow or charting problem, not a global one. Two subtle traps: a repeat exposes the patient a second time and wastes the tube's heat budget and department time, so the dose cost is never isolated; and "clinically the same, just darker" is a common wrong answer — if the anatomy is present, correctly positioned, and motion-free, the answer is to window the display, never to re-shoot. Keeping the first exposure diagnostic is therefore both a dose-protection and a quality metric.

Common Traps

Do not repeat an image merely because it looks too dark or too light on the monitor — window it. Do not withhold a medically necessary exam from a pregnant patient out of exaggerated fear; cite the NCRP low-dose context and optimize instead. And remember that a child is not simply a small adult: pediatric technique charts, immobilization, and Image Gently exist specifically because default adult factors over-irradiate.